Dreamforce 2018: Accelerate r&d and customer experience innovation in life sciences with MuleSoft
With the average cost of bringing a new drug to market exceeding $2.5B leading pharmaceutical companies have embraced API-led digital collaboration as a means of streamlining R&D innovation and accelerating the adoption of new products. Learn how Amgen, a leading global pharmaceutical company, has done so, using MuleSoft's Anypoint Platform to build and reuse APIs that optimize their product development pipeline.
Bob Hayden, Architect at Amgen
Matthew Serna, Industry GTM, Marketing & Solutions Lead at MuleSoft